NAVINFLUOR2024-01-012024-03-31 NAVINFLUOR2024-01-012024-03-31 NAVINFLUOR2024-01-012024-03-31in-bse-fin:OneOperatingExpenses01Member NAVINFLUOR2024-01-012024-03-31in-bse-fin:FourOperatingExpenses01Member NAVINFLUOR2024-03-31 NAVINFLUOR2024-01-012024-03-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member NAVINFLUOR2024-01-012024-03-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member NAVINFLUOR2024-01-012024-03-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member NAVINFLUOR2024-01-012024-03-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 532504 NAVINFLUOR NOTLISTED Navin Fluorine International Limited Equity 2023-04-01 2024-03-31 2024-05-07 2024-03-20 INR Crores Yearly 13:05:00 16:00:00 2024-05-07 2024-05-07 true Cash Flow Indirect Declaration of unmodified opinion Single segment Chemicals 2024-01-01 2024-03-31 Unaudited Consolidated 6019500000.00 125200000.00 6144700000.00 2699300000.00 14500000.00 296600000.00 712600000.00 174400000.00 257100000.00 1196000000.00 5350500000.00 794200000.00 0.00 794200000.00 -106100000.00 196500000.00 90400000.00 0.00 703800000.00 0.00 0.00 0.00 -100000.00 703700000.00 -8500000.00 695200000.00 703700000.00 0.00 695200000.00 0.00 99100000.00 2 14.20 14.18 0.00 0.00 14.20 14.18 3. The results of the quarter and year ended 31st March,2024 were reviewed by the Audit Committee and approved by the Board of Directors of the Company, at its meeting held on 7th May, 2024. 4. During the year, the Company paid an interim dividend of Rs.5/- per share (250%) plus a onetime special dividend of Rs.3/- per share (150%) on 495,72,535 equity shares of nominal value of Rs. 2/- each, aggregating to Rs 39.66 crores. The Board of Directors of the Company has recommended a final dividend of Rs.7/- per share (350%) on 4,95,73,400 equity shares of nominal value of Rs 2/- each, aggregating to Rs. 34.70 crores, subject to shareholders' approval in the forthcoming Annual General Meeting. 5. During the year ended 31st March, 2024, the company granted 2,27 ,500 stock options at the market price prevailing immediately before the grant date under Employee Stock Option Scheme 2017 (ESOP Schemes), as approved by Board of Directors to the selected employees across the Company. Further during the previous year ended 31st March,2023. the Board had approved the grant of 1,55,000 stock options at par under ESOP Schemes to the senior leadership of the Company. of these 1,05,000 unvested options have since lapsed. The overall net charge on account of aforementioned ESOP schemes / reversal consequent to lapse of 1,05,000 unvested options is as follows: (Rs in crores) Quarter ended Twelve months ended 31st Mar, 2024 31st Dec, 2023 31st Mar, 2023 31st Mar, 2024 31st Mar, 2023 5.34 2.50 9.31 1.47 16.79 6. Other income for the quarter and year ended 31st March, 2024 includes interest of Rs 1.20 crores and Rs 17.91 crores respectively on refund of income tax. (Quarter ended 31st December, 2023 is Rs 1.12 crores, Quarter ended 31st March, 2023 is Nil and year ended 31st March,2023 includes interest of Rs 0.91 crores). 7. Exceptional item for the quarter ended 31st December, 2023 and year ended 31st March, 2024 comprises gain of Rs 52.13 crore on account of sale of surplus unused colony land situated at Surat (Gujarat). 8. Tax expense for the quarter and year ended 31st March,2024 includes reversal of excess provision of tax for earlier years amounting Rs 16.97 crores and Rs 26.09 crores respectively. (Quarter ended 31st December, 2023 is Rs 6.61 crores). 9. In the Consolidated results, the figures for the quarter ended 31 st March, 2024 and 31st March,2023 are balancing figures between the audited figures in respect of the full financial year and the published year to date figures up to the third quarter of the relevant financial year. 10. The consolidated results include the financial results of three foreign subsidiaries - Manchester Organics Limited, NFIL (UK) Limited and Navin Fluorine (Shanghai) Co. Limited, a step-down foreign subsidiary - NFIL USA Inc., a 100% subsidiary of NFIL (UK) Ltd., two Indian subsidiaries - Sulakshana Securities Limited and NFASL, a joint venture company - Swamim Gujarat Fluorspar Private Limited and a foreign branch - Zug. 11. The Group has identified Chemicals business as its only primary reportable segment in accordance with the requirements of lnd AS 108, 'Operating Segments'. Accordingly, no separate segment information has been provided. Single segment 2023-04-01 2024-03-31 Audited Consolidated 20650100000.00 558500000.00 21208600000.00 9022800000.00 94300000.00 237200000.00 2858400000.00 745600000.00 961600000.00 4454600000.00 18374500000.00 2834100000.00 521300000.00 3355400000.00 357000000.00 293300000.00 650300000.00 0.00 2705100000.00 0.00 0.00 0.00 -100000.00 2705000000.00 200000.00 2705200000.00 2705000000.00 0.00 2705200000.00 0.00 99100000.00 2 23727600000.00 54.57 54.49 0.00 0.00 54.57 54.49 Other Expenses 1196000000.00 Other Expenses 4454600000.00 17338700000.00 7110900000.00 505100000.00 877600000.00 24600000.00 0.00 0.00 7400000.00 80500000.00 0.00 2500000.00 233100000.00 316100000.00 0.00 2057500000.00 28237900000.00 3716500000.00 4860300000.00 5125100000.00 66400000.00 209000000.00 6100000.00 182500000.00 10449400000.00 0.00 1366200000.00 15532100000.00 0.00 0.00 43770000000.00 99100000.00 23727600000.00 23826700000.00 23826700000.00 10228600000.00 0.00 173000000.00 10401600000.00 184900000.00 643300000.00 0.00 134500000.00 11364300000.00 3170800000.00 3025000000.00 1851600000.00 8047400000.00 402600000.00 121200000.00 7800000.00 0.00 8579000000.00 0.00 0.00 19943300000.00 43770000000.00 745600000.00 964700000.00 506200000.00 0.00 779300000.00 0.00 0.00 0.00 0.00 1360100000.00 0.00 0.00 0.00 961600000.00 0.00 0.00 8000000.00 0.00 0.00 -14100000.00 0.00 0.00 14700000.00 -109500000.00 0.00 -53400000.00 -512400000.00 0.00 0.00 4650800000.00 8006200000.00 -300000.00 0.00 -32600000.00 342700000.00 -131700000.00 7498900000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 541300000.00 7323900000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 300000.00 32600000.00 0.00 -4184800000.00 0.00 -10934500000.00 0.00 0.00 0.00 0.00 0.00 0.00 900000.00 0.00 4912900000.00 0.00 0.00 66000000.00 744900000.00 745600000.00 0.00 0.00 3357300000.00 -78300000.00 0.00 -78300000.00 144700000.00 66400000.00 Remeasurement loss of the defined benefit obligation -3800000.00 Remeasurement loss of the defined benefit obligation -8500000.00 -3800000.00 -8500000.00 -1100000.00 -3100000.00 Exchange difference on translation of foreign operations -5800000.00 Exchange difference on translation of foreign operations 5600000.00 -5800000.00 5600000.00 0.00 0.00